Received Nov 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | U8923AA | OT |
patient jumped and moved away from the administering staff member in the middle of receiving the dose and received less than half of the approved dose with no reported adverse event; Initial information received on 14-Nov-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a patient of unknown age and unknown gender who jumped and moved away from the administering staff member in the middle of receiving the dose and received less than half of the approved dose of influenza trivalent recombinant vaccine [flublok TIV] with no reported adverse event. The patient's past medical history, medical treatment(s), concomitant medication(s), vaccination(s), family history were not provided. On 07-Nov-2025, the patient jumped and moved away from the administering staff member in the middle of receiving the dose and received less than half of the approved dose of 0.5 ml of influenza trivalent recombinant vaccine solution for injection (strength: standard, frequency: once) (batch number: U8923AA and expiry date: 30-JUN-2026) via intramuscular route in unknown administration site for immunization with no reported adverse event (incomplete dose administered) (Latency same day). Action taken: Not applicable This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.